Caron Products and Services
  • Status Current Investment
  • Location Marietta, OH
  • Industry Industrial and Life Sciences Technology
  • Investment Date December 2020


Caron is a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell and gene therapy, and academic research.

Value proposition

Helps its customers with FDA-required QA/QC stability testing during drug development and manufacturing, incubation in clean-room environments, and growth of samples in academic research.


Leading companies in the biopharmaceutical, biotechnology, outsourced pharmaceutical services, consumer products, and academic industries, among others.

Related News
Jan 25 2023
Caron Receives Patents for Humanity COVID-19 Program Award from the United States Patent and Trademark Office
Oct 27 2022
Caron Products Names Tom Kroeger Global Director of Quality
Aug 2 2022
Caron Products Names Sharon Moseley Global Human Resources Director
Jul 13 2022
Luke Denly Joins Caron as Global Director of Marketing
Jun 24 2022
Caron Products Expands Its Brand, Integrating UK-based Bigneat
Jun 18 2022
Caron Products Welcomes Joshua Campbell in Newly Created Corporate Controller Role
May 6 2022
Caron Products Welcomes Joseph Chin in Newly Created Director of Global Strategic Sourcing Role
Mar 25 2022
Caron Products Names Dr. Jitendra Pant, ME, PhD as Global Director of Research and Innovation and Alan Campbell , MBA as Global Director of Product Marketing and Brand Management.
Mar 1 2022
Sayeh Beiglari Joins Caron as Global VP of Sales
Aug 16 2021
SFW Capital-backed Caron Completes Acquisition of Bigneat
May 26 2021
Caron Appoints Jay Hexamer New President and CEO
May 5 2021
Caron Adds Experienced Life Sciences and Lab Products Executive Mark McLoughlin to Board of Directors
Jan 13 2021
SFW Capital Completes Strategic Recapitalization of Caron Products and Services